Thiamine (Intsimbi Yokutya Kwegazi)
Thiamine
Gr Pharmaceuticals (1967) (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Gr Pharmaceuticals (1967) (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Intsimbi yokutya kwegazi EACH 5 ML SYRUP CONTAINS THIAMINE HYDROCHLORIDE A 7,590 MG | Not listed | H0835 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Vitamin b1
- and derivatives thereof
- in preparations thereof for injection; (S0)
- except in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)
Consolidated Schedules 06 July 2026, lines 4392 to 4397
S1: Vitamin b1
- and derivatives thereof
- in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
- except in preparations thereof for injection. (S3)
Consolidated Schedules 06 July 2026, lines 1149 to 1154
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-[3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol
Drag to rotate. Structure from PubChem CID 1130.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.